Prospective observational study of tofacitinib in ulcerative colitis - analysis of clinical data, fatigue and health-related quality of life during the induction phase.
Authors
Ola Olén (ORCID: https://orcid.org/0000-0002-5478-7019)
S Jónsdóttir
Hans Strid (ORCID: https://orcid.org/0000-0003-4651-6769)
Henrik Hjortswang (ORCID: https://orcid.org/0000-0001-6352-5419)
Jonas Halfvarson (ORCID: https://orcid.org/0000-0003-0122-7234)
Dan Henrohn (ORCID: https://orcid.org/0000-0001-9514-1153)
Charlotte Hedin (ORCID: https://orcid.org/0000-0002-4921-8516)
Jonas K. Söderling (ORCID: https://orcid.org/0000-0001-9006-2835)
Maria Seddighzadeh
Jan Marsal (ORCID: https://orcid.org/0000-0003-4808-0014)
Joseph C. Cappelleri (ORCID: https://orcid.org/0000-0001-9586-0748)
Lisa Nyberg (ORCID: https://orcid.org/0000-0001-8102-4458)
Prospective observational study of tofacitinib in ulcerative colitis - analysis of clinical data, fatigue and health-related quality of life during the induction phase.
Ola Olén, S Jónsdóttir, Hans Strid, Henrik Hjortswang et al.
Local Database Links
1 links
Journal
PubMed
Topics
Microscopic Colitis
article
Prospective observational study of tofacitinib in ulcerative colitis - analysis of clinical data, fatigue and health-related quality of life during the induction phase.
Ola Olén, S Jónsdóttir, Hans Strid, Henrik Hjortswang, Jonas Halfvarson, Dan Henrohn, Charlotte Hedin, Jonas K. Söderling, Maria Seddighzadeh, Jan Marsal, Joseph C. Cappelleri, Lisa Nyberg, Olof Grip
article en
Abstract
No abstract available for this paper.
Publication Tag
PubMedVol. 18
Institutions
Linköping University (SE), Uppsala University (SE), Karolinska University Hospital (SE), Pfizer (United States) (US), Lund University (SE), Örebro University (SE), Karolinska Institutet (SE), Pfizer (Sweden) (SE), Stockholm South General Hospital (SE), Skåne University Hospital (SE), Statistical Research (United States) (US)
Funders
Falk Foundation, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Gilead Sciences, Karolinska Institutet, Vifor Pharma, Tillotts Pharma, Norgine
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Prospective observational study of tofacitinib in ulcerative colitis - analysis of clinical data, fatigue and health-related quality of life during the induction phase. — Ola Olén, S Jónsdóttir, et al. · PubMed (2025) | TGRS Research Map | TGRS